MannKind (MNKD) Announces Completion of $10.2M Insulin Sales Agreement with Sanofi (SNY)
Tweet Send to a Friend
MannKind (NASDAQ: MNKD) disclosed the following in a U.S. SEC filing on Wednesday:Item 2.01 Completion of Acquisition or Disposition of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE